By Kimberly Chin

Nevro Corp. is expected to pay $20 million to Boston Scientific Corp. after a Delaware jury found that the medical device company had infringed on two Boston Scientific patents related to the manufacturing of a spinal cord stimulation technology, the company said late Monday.

The jury found that Nevro infringed on two lead patents involving the ways spinal cord stimulation technology were manufactured. The manufacturing methods were implemented by a third-party supplier, Nevro said. Two other Boston Scientific patents weren't infringed.

"We disagree with the finding by the jury and plan to appeal," Nevro General Counsel Kashif Rashid said in a release.

Boston Scientific representatives couldn't immediately be reached for comment.

The jury's decision doesn't have any commercial implications or place any restrictions on current or future Nevro products, the Redwood City, Calif., company said. The amount of money that will be awarded to Boston Scientific won't have a material effect on its business, Nevro said.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

November 01, 2021 19:36 ET (23:36 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Boston Scientific.
Boston Scientific (NYSE:BSX)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Boston Scientific.